Market Report On WFMI, PWRM, CTRP and BMC From DrStockPick.com!

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases.
By: Karl McMahon
 
Nov. 11, 2010 - PRLog -- Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.

"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

************************************************

BMC Software Inc.  ServiceDesk on Force.com, which combines BMC’s best-in-class service desk solution with cloud computing, is now available for immediate test drive and deployment on AppExchange 2. Customers save money and get better help desk results with BMC ServiceDesk on Force.com, which is powered by enterprise cloud leader salesforce.com. BMC will be attending Dreamforce 2010, the cloud computing event of the year, at Moscone Convention Center in San Francisco December 6-9, 2010. Be sure to stop by booth 425 for a demo and more information.

BMC Software, Inc. develops software that provides system and service management, and automation solutions primarily for enterprises in the United States and internationally.

************************************************

Ctrip.com International Ltd.  a leading travel service provider for hotel accommodations, airline tickets, packaged tours and corporate travel management in China, announced its unaudited financial results for the third quarter ended September 30, 2010. Net revenues were RMB812 million (US$121 million) for the third quarter of 2010, up 49% year-on-year. In the third quarter, Wing On Travel and ezTravel contributed 11% for the year-on-year growth for net revenues. Gross margin was 78% for the third quarter of 2010, compared to 77% in the same period in 2009.Income from operations was RMB308 million (US$46 million) for the third quarter of 2010, up 55% year-on-year. Excluding share-based compensation charges (non-GAAP), income from operations was RMB368 million (US$55 million), up 63% year-on-year. Operating margin was 38% for the third quarter of 2010. Net income attributable to Ctrip’s shareholders was RMB320 million (US$48 million) in the third quarter of 2010, up 70% year-on-year. Excluding share-based compensation charges (non-GAAP), net income attributable to Ctrip’s shareholders was RMB380 million (US$57 million), up 77% year-on-year.

************************************************

Whole Foods Market, Inc.  announced it is launching a fundraising campaign to support Share Our Strength’s new No Kid Hungry Campaign. Share Our Strength’s No Kid Hungry Campaign™ is a national effort to end childhood hunger in America by 2015. Share Our Strength works with state, community and private sector leaders across the country to connect families facing hunger with the programs that can help them.

Whole Foods Market, Inc. engages in the ownership and operation of natural and organic food supermarkets. The company offers seafood, grocery, meat and poultry, bakery, prepared foods and catering, coffee and tea, nutritional supplements, and vitamins.

************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer ) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).
End



Like PRLog?
9K2K1K
Click to Share